LOréal

L'Oréal Issues Urgent Recall of Acne Treatment Amid Cancer Risks

7 hours ago

In a significant safety alert for consumers, L'Oréal has announced a recall of its acne treatment product, "La Roche-Posay Effaclar Deep Cleansing Foaming Cream," due to the presence of benzene, a chemical that has been linked to cancer. This recall affects a considerable number of units sold across the United States, raising concerns among users about the ongoing safety of skincare products and the regulation of chemicals used in cosmetics.

L'Oréal's Sales Fall Short of Expectations Amid Weak Demand in China

1 month ago

In a significant development for the beauty industry, L'Oréal has reported sales figures that have fallen short of market expectations as demand in China continues to stagnate. The French cosmetics giant, renowned for its expansive portfolio of skincare, haircare, and makeup products, recorded a revenue growth of just 5.5% in the last quarter, below analysts' projections of 7% growth. This disappointing performance has sparked concerns about the brand's ability to rebound in a crucial market.

L'Oréal to Sell $3 Billion Worth of Sanofi Shares Back to Pharmaceutical Giant

1 month ago

In a significant financial maneuver, L'Oréal has announced plans to divest a substantial portion of its stake in Sanofi, the internationally recognized French pharmaceutical company. The beauty giant is set to sell approximately $3 billion worth of shares back to Sanofi in a move that is expected to strengthen both companies' financial standings while streamlining their operations.